Pulmonary hypertension and Left ventricular hypertrophy

Summary:

Left ventricular hypertrophy is found among people with Pulmonary hypertension, especially for people who are female, 60+ old.

The study analyzes which people have Left ventricular hypertrophy with Pulmonary hypertension. It is created by eHealthMe based on reports of 15 people who have Pulmonary hypertension from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Pulmonary hypertension?

Pulmonary hypertension (increase in blood pressure in the lung artery) is found to be associated with 1,433 drugs and 1,298 conditions by eHealthMe. Check the latest studies of Pulmonary hypertension.

What is Left ventricular hypertrophy?

Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart) is found to be associated with 899 drugs and 755 conditions by eHealthMe. Check the latest studies of Left ventricular hypertrophy.

On Jul, 16, 2026

15 people who have Pulmonary Hypertension and Left Ventricular Hypertrophy are studied.

Would you have Left ventricular hypertrophy when you have Pulmonary hypertension?

Gender of people who have Pulmonary Hypertension and experienced Left Ventricular Hypertrophy *:

female: 86.67 %
male: 13.33 %

Age of people who have Pulmonary Hypertension and experienced Left Ventricular Hypertrophy *:

Common co-existing conditions for these people *:

Fluid Overload (too much fluid in the blood): 4 people, 26.67%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 20.00%
Myoclonic Epilepsy (type of epilepsy with quick little jerks of the arms, shoulder, or occasionally the legs): 2 people, 13.33%
Agitation (state of anxiety or nervous excitement): 2 people, 13.33%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 6.67%
Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 1 person, 6.67%
Stress And Anxiety: 1 person, 6.67%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 6.67%
Raynaud's Phenomenon (discoloration of the fingers, toes, and occasionally other areas): 1 person, 6.67%
Iron Deficiency Anaemia: 1 person, 6.67%

Common drugs taken by these people *:

Common symptoms for these people *:

Dyspnea (difficult or laboured breathing): 11 people, 73.33%
Fluid Overload (too much fluid in the blood): 8 people, 53.33%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 8 people, 53.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 46.67%
Rashes (redness): 6 people, 40.00%
Dyspnea Exertional: 6 people, 40.00%
Diarrhea: 6 people, 40.00%
Headache (pain in head): 6 people, 40.00%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 6 people, 40.00%
Nausea (feeling of having an urge to vomit): 6 people, 40.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Left ventricular hypertrophy?

- Check whether Left ventricular hypertrophy is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Left ventricular hypertrophy and Pulmonary hypertension, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.